NN Investment Partners Holdings N.V. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
NN Investment Partners Holdings N.V. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$635,000
-33.7%
14,118
-16.7%
0.00%
-33.3%
Q4 2020$958,000
+41.7%
16,954
+19.1%
0.01%
+50.0%
Q3 2020$676,000
-17.5%
14,235
+2.6%
0.00%
-33.3%
Q2 2020$819,000
+5018.8%
13,881
+1883.0%
0.01%
Q2 2016$16,000
-42.9%
7000.0%0.00%
Q1 2016$28,0007000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders